A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis
- 11 June 2010
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 81 (9), 1033-1038
- https://doi.org/10.1136/jnnp.2010.206623
Abstract
Objective A stratified, randomised, waitlist controlled study over 12 months assessed the effectiveness of a 6 week bladder rehabilitation programme in persons with multiple sclerosis (pwMS) in an Australian community cohort. Methods Patients with definite MS and bladder issues (n=74) recruited from a tertiary hospital database were randomised to a treatment group (n=40) for an individualised bladder rehabilitation programme or to a control waitlist group (n=34). The Urogenital Distress Inventory (UDI6), Neurological Disability Scale (NDS) and the American Urological Association Symptom Index (AUA) assessed bladder impairment and ‘activity limitation’; a single Quality of life (QoL) item in the AUA and the Incontinence Impact Questionnaire (IIQ7) measured restriction in ‘participation’. Primary outcome measures were assessed at baseline and at 12 months. Results Analysis of per protocol data from 58 patients (treatment n=24, control n=34) showed reduced disability in the treatment group, with significant differences (p0.5) in post-treatment UDI6, NDS, AUA total, AUA QoL and IIQ7 scores for the two groups. The treatment group compared with the control group showed improvement: 78% versus 27% for UDI6 and 59% versus 17% improved for IIQ7. More patients in the control group deteriorated over the study period on the UDI6 (30% vs 0%; pConclusion A multifaceted, individualised bladder rehabilitation programme reduces disability and improves QoL in pwMS compared with no intervention after 12 months of follow-up. Information on specific interventions in different bladder types in MS and the impact on QoL need further evaluation. Australian Clinical trials Registry ACTRNO12605000676617.Keywords
This publication has 31 references indexed in Scilit:
- Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunctionMultiple Sclerosis Journal, 2009
- Spastic paretic hemifacial contracture in multiple sclerosis: a neglected clinical and EMG entityMultiple Sclerosis Journal, 2008
- The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)Journal of Neurology, Neurosurgery & Psychiatry, 2007
- Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosisDisability and Rehabilitation, 2007
- Use of international classification of functioning, disability and health (ICF) to describe patient-reported disability in multiple sclerosis and identification of relevant environmental factorsActa Dermato-Venereologica, 2007
- Normative values for the American Urological Association Symptom Index (AUA‐7) and short form Urogenital Distress Inventory (UDI‐6) in patients 65 and older presenting for non‐urological careNeurourology and Urodynamics, 2005
- Bladder, Bowel and Sexual Dysfunction in Multiple SclerosisDrugs, 2003
- The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosisMultiple Sclerosis Journal, 1999
- Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcomeMultiple Sclerosis Journal, 1999
- Rating neurologic impairment in multiple sclerosisNeurology, 1983